As the biomarker market continues to advance, its complexity grows as well. It is essential that the industry is in tune with the latest developments and breakthroughs. A wide variety of important topics will be covered, including biomarker identification, validation, translation strategies, bioinformatics and systems biology approaches to personalized medicine, big data analytics and management, companion diagnostics development, and much more. These areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector.